A NOVEL CYP2D6 ALLELE WITH AN ABOLISHED SPLICE RECOGNITION SITE ASSOCIATED WITH THE POOR METABOLIZER PHENOTYPE

被引:44
作者
MAREZ, D
SABBAGH, N
LEGRAND, M
LOGUIDICE, JM
BOONE, P
BROLY, F
机构
[1] Laboratoire de Biochimie et Biologie Moléculaire de l’Hôpital Calmette, Centre Hospitalier Régional et Universitaire de Lille, Lille, 59037, Bd. J. Leclercq
来源
PHARMACOGENETICS | 1995年 / 5卷 / 05期
关键词
CYP2D6; PCR-SSCP; PHARMACOGENETIC; DEBRISOQUINE; GENOTYPING;
D O I
10.1097/00008571-199510000-00006
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A novel loss-of function allele of the CYP2D6 gene was characterized in a PM individual using exon-by-exon PCR-SSCP analysis. This allele, we termed CYP2D6(F), harbours four mutations including a new mutation (D6-F) which abolishes the splice acceptor site of the Ist intron and results in a premature stop codon, DNA samples from a large population of healthy unrelated volunteers were tested for D6-F using a PCR-assay we developed for the specific identification of the mutation in genomic DNA. The prevalence of D6-F was very low. However, its identification combined with that of the previously reported gene inactivating mutations would further increase the phenotype prediction rate by genotyping.
引用
收藏
页码:305 / 311
页数:7
相关论文
共 32 条
[21]   EVOLUTION OF A HIGHLY POLYMORPHIC HUMAN CYTOCHROME P450 GENE-CLUSTER - CYP2D6 [J].
HEIM, MH ;
MEYER, UA .
GENOMICS, 1992, 14 (01) :49-58
[22]   INHERITED AMPLIFICATION OF AN ACTIVE GENE IN THE CYTOCHROME-P450 CYP2D LOCUS AS A CAUSE OF ULTRARAPID METABOLISM OF DEBRISOQUINE [J].
JOHANSSON, I ;
LUNDQVIST, E ;
BERTILSSON, L ;
DAHL, ML ;
SJOQVIST, F ;
INGELMANSUNDBERG, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) :11825-11829
[23]  
KAGIMOTO M, 1990, J BIOL CHEM, V265, P17209
[24]   INTERETHNIC VARIATION OF DRUG-METABOLISM [J].
KALOW, W .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1991, 12 (03) :102-107
[25]  
KIMURA S, 1989, AM J HUM GENET, V45, P889
[26]   IDENTIFICATION OF A NEW VARIANT CYP2D6 ALLELE WITH A SINGLE-BASE DELETION IN EXON-3 AND ITS ASSOCIATION WITH THE POOR METABOLIZER PHENOTYPE [J].
SAXENA, R ;
SHAW, GL ;
RELLING, MV ;
FRAME, JN ;
MOIR, DT ;
EVANS, WE ;
CAPORASO, N ;
WEIFFENBACH, B .
HUMAN MOLECULAR GENETICS, 1994, 3 (06) :923-926
[27]   2 MUTANT ALLELES OF THE HUMAN CYTOCHROME-P-450DB1 GENE (P450C2D1) ASSOCIATED WITH GENETICALLY DEFICIENT METABOLISM OF DEBRISOQUINE AND OTHER DRUGS [J].
SKODA, RC ;
GONZALEZ, FJ ;
DEMIERRE, A ;
MEYER, UA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (14) :5240-5243
[28]   DEBRISOQUINE HYDROXYLASE GENE POLYMORPHISM AND SUSCEPTIBILITY TO PARKINSONS-DISEASE [J].
SMITH, CAD ;
GOUGH, AC ;
LEIGH, PN ;
SUMMERS, BA ;
HARDING, AE ;
MARANGANORE, DM ;
STURMAN, SG ;
SCHAPIRA, AHV ;
WILLIAMS, AC ;
SPURR, NK ;
WOLF, CR .
LANCET, 1992, 339 (8806) :1375-1377
[29]   A NOVEL CYTOCHROME-P-450IID6 MUTANT-GENE ASSOCIATED WITH PARKINSONS-DISEASE [J].
TSUNEOKA, Y ;
MATSUO, Y ;
IWAHASHI, K ;
TAKEUCHI, H ;
ICHIKAWA, Y .
JOURNAL OF BIOCHEMISTRY, 1993, 114 (02) :263-266
[30]  
TUCKER GT, 1994, J PHARM PHARMACOL, V46, P417